Moderna has “paused its efforts” to build an mRNA vaccine manufacturing facility in Kenya while it determines future demand for mRNA vaccines on the African continent.
“The demand in Africa for COVID-19 vaccines has declined since the pandemic and is insufficient to support the viability of the factory planned in Kenya. Moderna has not received any vaccine orders for Africa since 2022 and has faced the cancellation of previous orders, resulting in more than $1 billion in losses and write-downs,” the COVID-19 jab manufacturer announced last week.
“Despite these challenges, Moderna is committed to ensuring equitable access and meeting emerging demands from African nations for its COVID-19 vaccine through its global manufacturing network,” it added.
Moderna halts vaccine plant in Africa amid dwindling orders
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!